Ferrarotto, R., Testa, L., Riechelmann, R., Saad, M., Siqueira, L., Costa, F., & Hoff, P. (2011). 6598 POSTER Combination of Capecitabine and Oxaliplatin (CAPOX) is an Effective Option for the Treatment of Neuroendocrine Tumours (NET). European Journal of Cancer, 47, S471. https://doi.org/10.1016/S0959-8049(11)71909-8
Chicago Style (17th ed.) CitationFerrarotto, R., L. Testa, R.R Riechelmann, M. Saad, L.T Siqueira, F.P Costa, and P.M Hoff. "6598 POSTER Combination of Capecitabine and Oxaliplatin (CAPOX) Is an Effective Option for the Treatment of Neuroendocrine Tumours (NET)." European Journal of Cancer 47 (2011): S471. https://doi.org/10.1016/S0959-8049(11)71909-8.
MLA (9th ed.) CitationFerrarotto, R., et al. "6598 POSTER Combination of Capecitabine and Oxaliplatin (CAPOX) Is an Effective Option for the Treatment of Neuroendocrine Tumours (NET)." European Journal of Cancer, vol. 47, 2011, p. S471, https://doi.org/10.1016/S0959-8049(11)71909-8.